Grundy, a the University of Texas Southwestern cardiologist who co-wrote the U.S. cholesterol guidelines, has argued that increasingly, clinical trials must use endpoints that lump together various kinds of heart problems if they have a hope of proving the benefits of drugs.
FORBES: Has Lipitor Reached Its Limit?